Akanda Corp (AKAN) Stock Analysis
Verdict: AVOID
Terminal fundamental decline meets speculative volatility; AKAN is a deteriorating micro-cap with no path to solvency without massive dilution.
Investment score: 12/100
Analysis as of
Is Akanda Corp stock worth reviewing? AI model thesis
Akanda Corp is a fundamentally broken medicinal cannabis play with a negative net worth and evaporating revenue. While the stock exhibits extreme short-term volatility (Beta 14.1) attractive to day traders, the massive annual losses ($45.6M on $0.25M revenue) and current ratio of 0.58 signal imminent liquidity failure.
7-factor investment score
- Valuation: 10/100 (weight 20%)
- Financial Health: 2/100 (weight 15%)
- Technical Momentum: 25/100 (weight 15%)
- Earnings Quality: 5/100 (weight 15%)
- Insider Sentiment: 20/100 (weight 10%)
- Analyst Consensus: 0/100 (weight 10%)
- Risk-Adjusted Return: 15/100 (weight 15%)
Akanda Corp opportunities and risks
What speaks for AKAN
- Speculative Short Squeeze Potential
What speaks against AKAN
- Imminent Insolvency and Cash Exhaustion
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| AKAN | n/a | 0.9x | n/a | -382.7% | -17658.5% | -3304.7% |
| SAR.L | n/a | 0.0x | n/a | 0.0% | 0.0% | -8.9% |
| IMM.L | n/a | 0.0x | n/a | 0.0% | 0.0% | -11.2% |
| NFX.L | 4.7x | 0.0x | n/a | 0.0% | 0.0% | -16.8% |
| FUM.L | n/a | 0.8x | 0.4x | 73.1% | -534.6% | -402.8% |
| Peer median | n/a | 0.0x | n/a | 0.0% | 0.0% | -14.0% |
Frequently asked questions about Akanda Corp (AKAN)
Is AKAN stock a good investment?
The cached TradeMates AI model rates Akanda Corp as AVOID with an investment score of 12/100. Akanda Corp is a fundamentally broken medicinal cannabis play with a negative net worth and evaporating revenue. While the stock exhibits extreme short-term volatility (Beta 14.1) attractive to day traders, the massive annual losses ($45.6M on $0.25M revenue) and current ratio of 0.58 signal imminent liquidity failure. This is algorithmic model output, not personal investment advice.
Is AKAN stock a buy?
The TradeMates model verdict for AKAN is AVOID with an investment score of 12/100. Treat this as a model signal to review, not a personal buy recommendation.